wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33822560-F383479C-4A69-4CE5-A063-EB2857572A6C
Q33822560-F383479C-4A69-4CE5-A063-EB2857572A6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33822560-F383479C-4A69-4CE5-A063-EB2857572A6C
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
P2860
Q33822560-F383479C-4A69-4CE5-A063-EB2857572A6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33822560-F383479C-4A69-4CE5-A063-EB2857572A6C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e753f1cbf75ec1b6bb2e61d1855b94564162b12a
P2860
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer.